Dr. Yegang Ma 马业罡
Chief Physician
Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of lung, esophageal, and cardia cancers. Expertise in thoracoscopic minimally invasive surgery, radiofrequency ablation, mediastinoscopy, and management of mediastinal tumors.
Dr. Ma earned a PhD in thoracic surgery from China Medical University in 2006 and trained in minimally invasive thoracic tumor treatment at Shanghai Chest Hospital (2002–2003). A chief physician at Liaoning Cancer Hospital, Dr. Ma has published over 30 papers, including 15 SCI-indexed articles, and serves as a reviewer for the Journal of Cellular Biochemistry.
Professional roles
- Member, Thoracic and Cardiovascular Surgery Branch, Chinese Medical Association
- Member, Thoracic Surgery Branch, Liaoning Medical Association
- Standing Committee Member, Youth Professional Committee, Thoracic Surgery Branch, Liaoning Medical Association
- Editorial Board Member, Chinese Journal of Thoracic Surgery
Name order: in Chinese the family name comes first (Ma Yegang). Papers usually list the name as Yegang Ma or Ma Y.
Selected publications
32 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): Correction: Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients. PubMed 41673869
- Cell Death Discov, 2025 (senior author): Exploring the metabolic signaling network of GFPT in cancer. PubMed 40830088
- J Transl Med, 2025 (senior author): Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients. PubMed 40098145
- Bioengineered, 2021 (senior author): E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375. PubMed 34699320
- Front Mol Biosci, 2021 (senior author): Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma. PubMed 34568427
- Cancer Manag Res, 2020 (senior author): ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway. PubMed 33116826
- J BUON, 2020 (senior author): Fast-track surgery in single-hole thoracoscopic radical resection of lung cancer. PubMed 33099909
- Onco Targets Ther, 2019 (senior author): The tumor suppressive roles of ARHGAP25 in lung cancer cells. PubMed 31692494
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion